Relating a Conceptual Overview of Vaccines Utilization for the Prevention of Rotavirus in Children
Digital Object Identifier:
10.58578/mikailalsys.v1i2.1736
Viewed : 114 times
Downloaded : 107 times
Please do not hesitate to contact us if you would like to obtain more information about the submission process or if you have further questions.
Abstract
Rotavirus infection is an emphatic health concern that when left unabated elicits hospitalizations, and deaths of many children due to diarrhea, even in developed countries; let one in poor settings. Likewise, the virus can affect older youngsters and adults resulting in mild infection. The consequences of the rotavirus could not be unconnected with the levels of poor prevention ploys put in place, including the inability of the body of children to counteract the rotavirus with a substantial immunity due to earlier invasion. Thus, it is important to seek for vaccines, because vaccination use in disease prevention is becoming a forefront efficient and easiest way nowadays. This paper brings a conceptual overview of vaccines utilization for the prevention of rotavirus infection in children under the following headings: Introduction, rotavirus vaccines, replicating vaccines, non-replicating vaccines, subunit vaccines, virus like particles, encapsulation, rotavirus vaccination, and conclusion.
Citation Metrics:
Downloads
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
References
Abramson, J.S., Baker, C. J. and Fisher, M. C, (1999). Possible association of intussusception with rotavirus vaccination. American Academy of Pediatrics. Committee on Infectious Diseases. Pediatrics; 104: 575.
Ahmed, M. U., Kobayashi, N., Wakuda, M., Sanekata, T., Taniguchi, K., Kader, A., Naik, T. N., Ishino, M, Alam, M. M., Kojima, K., Mise, K. and Sumi, A. (2004). "Genetic analysis of group B human rotaviruses detected in Bangladesh in 2000 and 2001". Journal of Medical Virology. 72 (1): 149–55.
Burnett, E., Parashar, U. and Tate, J. (2018). Rotavirus vaccines: effectiveness, safety, and future directions Paediatr Drugs, 20 (3): 223-233.
Burnett. E, Jonesteller, C.L, Tate, J.E, Yen, C. and Parashar, U.D (2017). "Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality from Diarrhea". The Journal of Infectious Diseases. 215 (11): 1666–72. doi:10.1093/infdis/jix186.
Carl, B. Karabocuoglu, M., Halicioglu, O., Anis, S. and Pawinski, R. (2019). Molecular characterization of rotavirus strains from pre- and post-vaccination periods in a country with low vaccination coverage: The case of Slovenia. Journal of general Virology; 73 (2):1939-76.
Cezard, J. P., Duhamel, J. F. and Meyer, M. (2001). Efficacy and ability of racecadotril in acute diarrhea in children. Gastroenterology toler; 120:799-805. [PubMed]
Charles, E. O. (2021). Introducing Rotavirus Vaccination in Nigeria: Economic Evaluation and Implications https://doi.org/10.1007/s41669-020-00251-6
Dan Brennan, M.D. (2020). Rotavirus (RV) Vaccine. Clinical Infectious Diseases; 50 (10): 1391–1401.
Doro, R., Laszlo, B., Martella, V., Leshem, E., Gentsch, J. and Parashar, U. (2014). Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: Is there evidence of strain selection from vaccine pressure? Infectious Genetic Evolution; 28:446–61. 25224179
Dorsey, M. Bass, M.D., Harry, B. and Greenberg, M.D (2017). Detection of group A rotavirus in infants with extrahepatic biliary atresia. Journal of Infectious Disease; 174: 8-15. [PubMed]
Fix A.D., Harro C., McNeal M., Dally L., Flores J. and Robertson G. (2015) Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults. Vaccine.;33:3766–3772.
GAVI. (2020). GAVI Co-Financing Information: Nigeria. 2019. https ://www.gavi.org/sites /defau lt/files /docum ent/co-finan cing-informatio n-sheet -niger iapdf .pdf. Accessed 6 Apr 2020.
Gratia, M., Vende, P., Charpilienne, A., Baron, H.C, Laroche, C, Sarot, E, Pyronnet, S., Duarte, M. and Poncet, D. (2016). "Challenging the Roles of NSP3 and Untranslated Regions in Rotavirus mRNA Translation". PLOS ONE. 11 (1):
Groome, M., J. (2016). Safety and immunogenicity of the P2-VP8∗ non-replicating rotavirus vaccine in South African infants. In: 12th International rotavirus symposium, Melbourne Australia; September 2016.
Institute for Health Metrics and Evaluation. Global Burden of Disease Study 2019 (2020). Results. Seattle, United States: 2019. http://ghdx.healt hdata .org/gbd-resul ts-tool. Accessed 11 July 2020.
International Vaccine Access Centre (IVAC, 2020). Current vaccine intro status. https://view-hub.org/map/?set=current-vaccine-intro-status&group=vaccine-introduction&category=rv (accessed Oct 21, 2020),
Jaakkola, E. (2020). Designing conceptual articles: Four approaches. AMS Review, DOI:10.1007/s3162-020-00161-0.
Jiang V, Jiang B, Tate J, Parashar UD and Patel MM (2010). "Performance of rotavirus vaccines in developed and developing countries". Human Vaccines. 6 (7): 532–42.
Lazarus, R., P., John, J. and Shanmugasundaram, E. (2018). The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: a randomized, factorial design, placebo-controlled study among Indian infants
Muhammed, A. M., Aminu, S. Ado, E. Jatau, and M. Esona (2016). “Prevalence of rotavirus among children under five years of age with diarrhea in Kaduna State, Nigeria,” Nigerian Journal of Paediatrics, 43 (4): 264–268.
Murphy, F.A., Gibbs, E.P.J., Horzinek, MC and Studdert, M.J. (1999): Reoviridae. In: F.A Murphy, E.P.J Gibbs, M.C Horzinek, and M. J studdert (eds), Veterinary virology, Academic press, USA. 391-400.
Murphy, TV, Gargiullo P.M. and Massoudi M.S. (2001). Intussusception among infants given an oral rotavirus vaccine. New England Journal of Medicine; 344:564-572.
Neupane, N. (2021). Conceptualizing the pathways of literature review in research. Journal of Practical Review in Research, 2(1):1-7.
Raju, V. & Phung, S.P. (2021). Resilient motive for reviewing literatures in business research: Exploring process of research design. Annals of RSCB, 25(4):6307-6428.
Saghi Nooraei, Howra Bahrulolum, Zakieh Sadat Hoseini, Camellia Katalani, Abbas Hajizade, Andrew, J. Easton and Gholamreza Ahmadian (2021). Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers Journal of Nanobiotechnology: 19 (59) : 115-120.
Saheri M, Nemarude L, peenze I and Netshithethe L. (2014). Incidence of rotavirus infection. The pediatric infectious Disease Journal, supply 1: S76-84
Simonsen, L., Morens, D. and Elixhauser, A. (2001). Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet; 358:1224-1229.
Ukazu, J. (2022). Dealing with diarrhoea: Nigeria introduces rotavirus vaccine into its immunisation plan. Journal of Microbiology: 26(2):154-65.
UNICEF Supply Division. Rotavirus vaccine: Supply and Demand update. 2020; February. https ://www.unice f.org/suppl y/sites /unice f.org.suppl y/files /2020-03/rotav irus-vacci ne-suppl y-and-deman d-updat e_0.pdf. Accessed 11 July, 2020. Vaccine, 36 (2): 273-279
Wang Y., Azevedo M., Saif L.J., Genstch J.R., Glass R.I. and Jiang B. (2015). Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine; 28:5432–5436.
Ward, R.L and Bernstein, D.I (2009). "Rotarix: a rotavirus vaccine for the world". Clinical Infectious Diseases. 48 (2): 222–8. doi:10.1086/595702. PMID 19072246
Wen X., Cao D., Jones R.W., Li J., Szu S. and Hoshino Y. (2012). Construction and characterization of human rotavirus recombinant VP8∗ subunit parenteral vaccine candidates. Vaccine. 30:6121–6126.
World Health Organization (2022). Summary of Key Characteristics of WHO Prequalified Rotavirus Vaccines. WHO position paper; 89:4-7. English and French (January 2022).
